Fibrosis - Pipeline Review, H2 2015

1
Fibrosis - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• - The report provides a snapshot of the global
  therapeutic landscape of Fibrosis
• - The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• - The report reviews key players involved in the
  therapeutics development for Fibrosis and enlists
  all their major and minor projects
• - The report summarizes all the dormant and
  discontinued pipeline projects
• - A review of the Fibrosis products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources
• - Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• - A detailed assessment of monotherapy and
  combination therapy pipeline projects
• - Coverage of the Fibrosis pipeline on the basis
  of target, MoA, route of administration and
  molecule type
• - Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/fibrosi
  s-pipeline-review-h2-2015-market

3


Table of Content
List of Figures List of Figures Number of
Products under Development for Fibrosis, H2 2015
11 Number of Products under Development for
Fibrosis - Comparative Analysis, H2 2015
12 Number of Products under Development by
Companies, H2 2015 13 Number of Products under
Investigation by Universities/Institutes, H2 2015
15 Comparative Analysis by Early Stage Products,
H2 2015 17 Assessment by Monotherapy Products, H2
2015 42 Number of Products by Top 10 Targets, H2
2015 43 Number of Products by Stage and Top 10
Targets, H2 2015 43 Number of Products by Top 10
Mechanism of Actions, H2 2015 45 Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 45 Number of Products by Routes
of Administration, H2 2015 47 Number of Products
by Stage and Routes of Administration, H2 2015
47 Number of Products by Top 10 Molecule Types,
H2 2015 49 Number of Products by Stage and Top 10
Molecule Types, H2 2015 49
4


Report Overview
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Fibrosis - Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline - Devise corrective
measures for pipeline projects by understanding
Fibrosis pipeline depth and focus of Indication
therapeutics - Develop and design in-licensing
and out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and scope - Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline Enquire At http//www.researchbeam.co
m/fibrosis-pipeline-review-h2-2015-market/enquire-
about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/fibrosis-pipeline-revi
ew-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com